IAVI Report

IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. It features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.

To access archived issues of IAVI Report dating back to 1996, click here.

Subscribe below to receive IAVI Report right to your inbox.

Questions/comments? Email us at iavireport@iavi.org.

Filter by

  • Health area

  • Locations

  • Topic

  • Year

  • Journal

  • Clear all

IAVI Report

Is stopping SARS-CoV-2 transmission an attainable goal?

February 15, 2023

Hundreds of next-generation COVID-19 vaccines are being explored, including many that are delivered mucosally to try to prevent infection or block transmission.

Read more

IAVI Report

The end of an era

December 20, 2022

After more than 50 years, Anthony Fauci leaves behind an unparalleled legacy of championing science, particularly HIV/AIDS treatment, prevention, and cure efforts.

Read more

IAVI Report

As Ebola outbreak fades, hope for a vaccine remains

December 14, 2022

The emergence of the Sudan strain of Ebola virus in Uganda prompted a rush to get vaccine candidates ready. Expectations are it will be needed in the future.

Read more

IAVI Report

Momentum against malaria

November 29, 2022

Two vaccines are poised for delivery against this old foe. What will it take for them to change the field?

Read more

IAVI Report

Monkeypox: What went right and what went wrong?

November 15, 2022

Chris Beyrer, director of the Duke Global Health Institute and a renowned epidemiologist, discusses the monkeypox outbreak and the U.S. response.

Read more

IAVI Report

Charting the way to a cure

November 1, 2022

HIV cure researchers are energized by news of another case of remission and the development of new tools that could help researchers evaluate how well other cure strategies are working.

Read more

IAVI Report

Upping the antibody

October 13, 2022

Therapeutic antibodies against SARS-CoV-2 were developed faster than any other intervention, but their use remains limited. What lessons are there for the development of other monoclonal antibody products, including those for HIV?

Read more

IAVI Report

Beyond a witches’ brew

July 26, 2022

An interview with Bali Pulendran on how adjuvants might extend the durability of mRNA-based vaccine protection.

Read more

IAVI Report

Data cabinets in the cloud

July 20, 2022

Clinical research data is precious. The IAVI DataSpace platform seeks better ways to store, manage, and share this information securely so it can be used to advance medical research.

Read more

IAVI Report

Can mRNA manufacturing become more global?

June 21, 2022

With pluck, persistence, and scientific prowess, more countries are gearing up to develop and produce the vaccines of the future.

Read more

IAVI Report

Is the next pandemic preventable?

June 8, 2022

COVID-19 has inspired many books about pandemic prevention, but reports show the world isn’t any better prepared today than it was before.

Read more

IAVI Report

Persistence pays: Researchers unravel mechanism of protection for a potential HIV vaccine vector

May 25, 2022

Scientists explain why a cytomegalovirus-vectored vaccine candidate, nearly 20 years in the making, produces promising results in monkeys. Will the same be true in humans?

Read more